Skip Navigation



Brain Advance Access published online on June 30, 2006
Brain, doi:10.1093/brain/awl152
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/8/2008    most recent
awl152v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Stefano, N.
Right arrow Articles by Amato, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Stefano, N.
Right arrow Articles by Amato, M. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received February 16, 2006
Revised April 10, 2006
Accepted May 11, 2006

Article

Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis

Nicola De Stefano 1 *, Marco Battaglini 1, M. L. Stromillo 1, Valentina Zipoli 2, M. L. Bartolozzi 3, Leonello Guidi 3, Gianfranco Siracusa 2, Emilio Portaccio 2, Antonio Giorgio 1, Sandro Sorbi 2, Antonio Federico 1, and Maria Pia Amato 2

1 Department of Neurological and Behavioral Sciences, University of Siena, Italy
2 Department of Neurology, University of Florence, Italy
3 Neurology Unit, Hospital of Empoli, Italy

* To whom correspondence should be addressed.
Nicola De Stefano, E-mail: destefano{at}unisi.it


  Abstract

The trend to start disease-modifying therapy early in the course of multiple sclerosis makes it important to establish whether the benign form is a real entity. In previous studies, measures of magnetization transfer (MT) ratio (MTr) have been shown to provide good estimates of the amount of tissue damage occurring in multiple sclerosis brains. Thus, with the hypothesis that if benign multiple sclerosis patients were really benign, sensitive measures of subtle tissue damage would be less pronounced in these patients than in very early relapsing-remitting (RR) multiple sclerosis patients. We carried out conventional MRI and MT imaging in 50 patients with benign multiple sclerosis [defined as having Kurtzke Expanded Disability Status Score (EDSS) <3 and disease duration >15 years] and in 50 early RR patients selected to have similar disability (EDSS <3) and short disease duration (<3 years). Data were compared with those of 32 demographically-matched normal controls. We used a fully automated procedure to measure lesional-MTr, perilesional-MTr, normal-appearing white matter (NAWM) MTr and cortical-MTr. We found that, after correction for common effects of age, lesional-MTr and perilesional-MTr of benign patients were significantly (P < 0.0001) lower than WM of normal controls, but significantly (P < 0.0001) higher than corresponding tissues of RR patients. In NAWM and cortex, MTr values of benign patients were similar to those of normal controls (P > 0.5) and significantly higher than those of the RR patients (P < 0.0001 and P < 0.01, respectively). Similar differences in MTr measures between benign and RR patients were found when patient groups were selected to have no disability (EDSS ≤ 2) and, for benign multiple sclerosis, very long disease duration (>20 years) or when both groups were matched for high lesion load (T2-weighted lesion volume >10 cm3). We conclude that lesional and non-lesional MTr values can be significantly less pronounced in benign multiple sclerosis than in a cohort of RR patients at their earliest disease stages, suggesting that brain tissue damage is milder in benign multiple sclerosis than in early RR disease. This can be due to an extraordinary beneficial response to demyelination of benign patients and may represent the evidence that benign multiple sclerosis truly exists and might be differentiated from other forms of this illness.

Keywords: multiple sclerosis; benign; magnetization transfer; demyelination; remyelination.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, S. Sorbi, et al.
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
Neurology, August 18, 2009; 73(7): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
S. Glad, H. Nyland, J. Aarseth, T Riise, and K. Myhr
Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway
Multiple Sclerosis, August 1, 2009; 15(8): 942 - 950.
[Abstract] [PDF]

Home page
 Mult SclerHome page
B Benedetti, M Rovaris, M. Rocca, D Caputo, M Zaffaroni, R Capra, A Bertolotto, V Martinelli, G Comi, and M Filippi
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis
Multiple Sclerosis, July 1, 2009; 15(7): 789 - 794.
[Abstract] [PDF]

Home page
 Mult SclerHome page
A Ceccarelli, M Filippi, M Neema, A Arora, P Valsasina, M. Rocca, B. Healy, and R Bakshi
T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis
Multiple Sclerosis, June 1, 2009; 15(6): 678 - 686.
[Abstract] [PDF]

Home page
 NeurologyHome page
M. Rovaris, F. Barkhof, M. Calabrese, N. De Stefano, F. Fazekas, D. H. Miller, X. Montalban, C. Polman, M. A. Rocca, A. J. Thompson, et al.
MRI features of benign multiple sclerosis: Toward a new definition of this disease phenotype
Neurology, May 12, 2009; 72(19): 1693 - 1701.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Daumer, A. Neuhaus, S. Morrissey, R. Hintzen, and G. C. Ebers
MRI as an outcome in multiple sclerosis clinical trials
Neurology, February 24, 2009; 72(8): 705 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. A. Gauthier, A. M. Berger, Z. Liptak, Y. Duan, S. Egorova, G. J. Buckle, B. I. Glanz, S. J. Khoury, R. Bakshi, H. L. Weiner, et al.
Rate of Brain Atrophy in Benign vs Early Multiple Sclerosis
Arch Neurol, February 1, 2009; 66(2): 234 - 237.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M Calabrese, M Filippi, M Rovaris, V Bernardi, M Atzori, I Mattisi, A Favaretto, P Grossi, L Barachino, L Rinaldi, et al.
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study
Multiple Sclerosis, January 1, 2009; 15(1): 36 - 41.
[Abstract] [PDF]

Home page
 NeurologyHome page
M. Rovaris, G. Riccitelli, E. Judica, F. Possa, D. Caputo, A. Ghezzi, A. Bertolotto, R. Capra, M. Falautano, F. Mattioli, et al.
Cognitive impairment and structural brain damage in benign multiple sclerosis
Neurology, November 4, 2008; 71(19): 1521 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. P. Amato, E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, et al.
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis
Neurology, August 26, 2008; 71(9): 632 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M Rovaris, E Judica, A Ceccarelli, A Ghezzi, V Martinelli, G Comi, and M Filippi
Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study
Multiple Sclerosis, July 1, 2008; 14(6): 853 - 856.
[Abstract] [PDF]

Home page
 StrokeHome page
E. Zicari, R. Tassi, M. L. Stromillo, M. Pellegrini, S. Bianchi, G. Cevenini, M. Gistri, N. De Stefano, A. Federico, and M. T. Dotti
Right-to-Left Shunt in CADASIL Patients: Prevalence and Correlation With Clinical and MRI Findings
Stroke, July 1, 2008; 39(7): 2155 - 2157.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
A. Hebb, C. Moore, V Bhan, T Campbell, J. Fisk, H. Robertson, M Thorne, E Lacasse, M Holcik, J Gillard, et al.
Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination
Multiple Sclerosis, June 1, 2008; 14(5): 577 - 594.
[Abstract] [PDF]

Home page
 Mult SclerHome page
S. Strasser-Fuchs, C. Enzinger, S. Ropele, M. Wallner, and F. Fazekas
Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
Multiple Sclerosis, March 1, 2008; 14(2): 205 - 211.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
C. Di Perri, M. Battaglini, M. L. Stromillo, M. L. Bartolozzi, L. Guidi, A. Federico, and N. De Stefano
Voxel-Based Assessment of Differences in Damage and Distribution of White Matter Lesions Between Patients With Primary Progressive and Relapsing-Remitting Multiple Sclerosis
Arch Neurol, February 1, 2008; 65(2): 236 - 243.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. P. Amato, N. De Stefano, H. L. Tremlett, A.-L. Sayao, and V. Devonshire
LONGITUDINAL FOLLOW-UP OF "BENIGN" MULTIPLE SCLEROSIS AT 20 YEARS
Neurology, August 28, 2007; 69(9): 938 - 939.
[Full Text] [PDF]

Home page
 Mult SclerHome page
H. Vrenken, P.J.W. Pouwels, S. Ropele, D.L. Knol, J.J.G. Geurts, C.H. Polman, F. Barkhof, and J.A. Castelijns
Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease
Multiple Sclerosis, July 1, 2007; 13(6): 708 - 716.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.